Amphora Medical Inc. closed a series B financing round for $35.5 million, led by Longitude Capital and Boston Scientific Corp. The Minneapolis, Minn.-based company will apply the funding to a trial for its Selective Bladder Denervation System among women with overactive bladder (OAB).

Quidel Corp. has agreed to take on Alere Inc.'s Triage portfolio, including Triage Meterpro's toxicology and cardiovascular, and B-type Naturietic Peptide (BNP) assay group for $400 million. The divestment will pave the way for Waltham, Mass.-based Alere to meet antitrust hurdles in its acquisition by Abbott Park, Ill.-based Abbott Laboratories.